The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid β-protein level in vivo

Annals of Neurology

Volumn 64, Issue 6, 2008, Pages 618-627

  Xie, Zhongcong ^a   Culley, Deborah J ^b   Dong, Yuanlin ^a   Zhang, Guohua ^a   Zhang, Bin ^a   Moir, Robert D ^a   Frosch, Matthew P ^a   Crosby, Gregory ^b   Tanzi, Rudolph E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CASPASE 3; CLIOQUINOL; ISOFLURANE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANESTHETICS, INHALATION; ANIMALS; BRAIN; CASPASES; ENZYME ACTIVATION; ISOFLURANE; MICE; MICE, INBRED C57BL;

EID: 58149269462     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21548     Document Type: Article

References (35)

1. Bohnen NI, Warner MA, Kokmen E, et al. Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc 1994;42:198-201.
2. Muravchick S, Smith DS. Parkinsonian symptoms during emergence from general anesthesia. Anesthesiology 1995;82:305-307.
3. Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005;7:319-324.
4. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122:1131-1135.
5. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005;120:545-555.
6. Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-741.
7. Gu Y, Misonou H, Sato T, et al. Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem 2001;276:35235-35238.
8. Sastre M, Steiner H, Fuchs K, et al. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2001;2:835-841.
9. Yu C, Kim SH, Ikeuchi T, et al. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. J Biol Chem 2001;276:43756-43760.
10. LeBlanc AC. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005;2:389-402.
11. van Groen T, Puurunen K, Maki HM, et al. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 2005;36:1551-1556.
12. Xie Z, Moir RD, Romano DM, et al. Hypocapnia induces caspase-3 activation and increases abeta production. Neurodegener Dis 2004;1:29-37.
13. Eckenhoff RG, Johansson JS, Wei H, et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004;101:703-709.
14. Xie Z, Dong Y, Maeda U, et al. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006;104:988-994.
15. Xie Z, Dong Y, Maeda U, et al. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci 2006;61:1300-1306.
16. Xie Z, Dong Y, Maeda U, et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007;27:1247-1254.
17. Zhang G, Dong Y, Zhang B, et al. Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine. J Neurosci 2008;28:4551-4560.
18. Zhang B, Dong Y, Zhang G, et al. The inhalation anesthetic desflurane induces caspase activation and increases amyloid-beta protein levels under hypoxic conditions. J Biol Chem 2008;283:11866-11875.
19. Cherny RA, Atwood CS, Xilinas ME, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001;30:665-676.
20. Thornberry NA. Caspases: key mediators of apoptosis. Chem Biol 1998;5:R97-R103.
21. Tesco G, Koh YH, Kang EL, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007;54:721-737.
22. Bianchi SL, Tran T, Liu C, et al. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 2007;29:1002-1010.
23. Velliquette RA, O'Connor T, Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci 2005;25:10874-10883.
24. Maekawa T, Tommasino C, Shapiro HM, et al. Local cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat. Anesthesiology 1986;65:144-151.
25. De Felice FG, Vieira MN, Saraiva LM, et al. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. Faseb J 2004;18:1366-1372.
26. Grace EA, Rabiner CA, Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 2002;114:265-273.
27. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A 1994;91:12243-12247.
28. Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998;95:6448-6453.
29. Wang HW, Pasternak JF, Kuo H, et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002;924:133-140.
30. Walsh DM, Klyubin I, Fadeeva JV, et al. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002;30:552-557.
31. Kim HJ, Chae SC, Lee DK, et al. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. Faseb J 2003;17:118-120.
32. Fujie W, Kirino T, Tomukai N, et al. Progressive shrinkage of the thalamus following middle cerebral artery occlusion in rats. Stroke 1990;21:1485-1488.
33. Nordborg C, Johansson BB. Secondary thalamic lesions after ligation of the middle cerebral artery: an ultrastructural study. Acta Neuropathol 1996;91:61-66.
34. Dijkhuizen RM, Knollema S, van der Worp HB, et al. Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: evidence for region-specific sensitivity and delayed damage. Stroke 1998;29:695-704.
35. Carmichael ST, Tatsukawa K, Katsman D, et al. Evolution of diaschisis in a focal stroke model. Stroke 2004;35:758-763.